PepGen appoints Paul Streck, M.D., MBA as EVP, Head of Research & Development

PepGen Inc.

Appoints Paul Streck, M.D., MBA as EVP, Head of R&D effective immediately, joining PepGen Executive Team.
Streck brings >20 yrs drug development experience; previously CMO at Albireo, Arena, Alder, Insmed, and roles at GSK, Shire, Amgen.
His accomplishments include five IND approvals, six global regulatory launches, nine commercial product launches.
CEO James McArthur cites Streck's value as PepGen advances four active clinical trials and preclinical pipeline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.